HomeCompareCKCB vs MRK

CKCB vs MRK: Dividend Comparison 2026

CKCB yields 200000.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CKCB wins by $4.911780474428384e+29M in total portfolio value
10 years
CKCB
CKCB
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full CKCB calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CKCB vs MRK

📍 CKCB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCKCBMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CKCB + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CKCB pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CKCB
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, CKCB beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CKCB + MRK for your $10,000?

CKCB: 50%MRK: 50%
100% MRK50/50100% CKCB
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CKCB
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CKCB buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCKCBMRK
Forward yield200000.00%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.911780474428384e+29M$57.7K
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00$10,113.78
Total dividends collected$4.911464459982279e+29M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CKCB vs MRK ($10,000, DRIP)

YearCKCB PortfolioCKCB Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,213$373.04+$20.00MCKCB
2$37,424,589,019$37,403,177,570.09$12,667$512.06+$37424.58MCKCB
3$65,416,215,188,220$65,376,170,877,969.18$14,439$708.14+$65416215.17MCKCB
4$106,868,230,495,008,900$106,798,235,144,757,520.00$16,640$988.16+$106868230494.99MCKCB
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$19,432$1,394.07+$163172871735896.84MCKCB
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$23,057$1,992.90+$232854599801468864.00MCKCB
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$27,889$2,894.79+$310570858137017057280.00MCKCB
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$34,518$4,286.29+$3.871481543016132e+23MCKCB
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$43,912$6,494.35+$4.510617497632811e+26MCKCB
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$57,714$10,113.78+$4.911780474428384e+29MCKCB

CKCB vs MRK: Complete Analysis 2026

CKCBStock

Clark County Bancorporation operates as the holding company for the Bank of Clark County that offers a range of financial products and services to businesses and individuals in the Clark County, Washington. The company's deposit products include personal checking accounts, money market accounts, savings and investment accounts, certificates of deposit, individual retirement accounts, business checking accounts, and business savings accounts. Its loan products comprise automobile loans, recreational vehicle loans, and home equity lines/loans; and lines of credit, term loans, SBA loans, seasonal loans, bridge loans, real estate loans, and letters of credit. The company also provides online banking, bill pay, automated teller machine, voice access, Visa debit card, cashier's checks and money orders, night depository, safe deposit boxes, wire transfers, traveler's checks, notary, credit cards, cash management, credit card processing, and courier services. Clark County Bancorporation was incorporated in 2001 and is headquartered in Vancouver, Washington.

Full CKCB Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CKCB vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CKCB vs SCHDCKCB vs JEPICKCB vs OCKCB vs KOCKCB vs MAINCKCB vs JNJCKCB vs ABBVCKCB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.